ANDA 211665, held by Strides Pharma. Potassium Chloride.
As of Nov 15, 2026, ANDA 211665 (Potassium Chloride), held by Strides Pharma, was first approved by FDA on Nov 17, 2022, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 17, 2022 | Original application | Approved | None posted |
| Potassium Chloride40MEQ/15ML · solution;oral | Potassium Chloride | Discontinued |
| Potassium Chloride20MEQ/15ML · solution;oral | Potassium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
